Expression and Activity of Phosphodiesterase Isoforms during Epithelial Mesenchymal Transition: The Role of Phosphodiesterase 4
- 15 November 2009
- journal article
- research article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 20 (22), 4751-4765
- https://doi.org/10.1091/mbc.e09-01-0019
Abstract
Epithelial-mesenchymal transition (EMT) has emerged as a critical event in the pathogenesis of organ fibrosis and cancer and is typically induced by the multifunctional cytokine transforming growth factor (TGF)-beta 1. The present study was undertaken to evaluate the potential role of phosphodiesterases (PDEs) in TGF-beta 1-induced EMT in the human alveolar epithelial type II cell line A549. Stimulation of A549 with TGF-beta 1 induced EMT by morphological alterations and by expression changes of the epithelial phenotype markers E-cadherin, cytokeratin-18, zona occludens-1, and the mesenchymal phenotype markers, collagen I, fibronectin, and alpha-smooth muscle actin. Interestingly, TGF-beta 1 stimulation caused twofold increase in total cAMP-PDE activity, contributed mostly by PDE4. Furthermore, mRNA and protein expression demonstrated up-regulation of PDE4A and PDE4D isoforms in TGF-beta 1-stimulated cells. Most importantly, treatment of TGF-beta 1 stimulated epithelial cells with the PDE4-selective inhibitor rolipram or PDE4 small interfering RNA potently inhibited EMT changes in a Smad-independent manner by decreasing reactive oxygen species, p38, and extracellular signal-regulated kinase phosphorylation. In contrast, the ectopic overexpression of PDE4A and/or PDE4D resulted in a significant loss of epithelial marker E-cadherin but did not result in changes of mesenchymal markers. In addition, Rho kinase signaling activated by TGF-beta 1 during EMT demonstrated to be a positive regulator of PDE4. Collectively, the findings presented herein suggest that TGF-beta 1 mediated up-regulation of PDE4 promotes EMT in alveolar epithelial cells. Thus, targeting PDE4 isoforms may be a novel approach to attenuate EMT-associated lung diseases such as pulmonary fibrosis and lung cancer.Keywords
This publication has 48 references indexed in Scilit:
- Transforming growth factor beta mediates hepatocyte apoptosis through Smad3 generation of reactive oxygen speciesBiochimie, 2007
- Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transitionJCI Insight, 2007
- TGF-β-induced EMT: mechanisms and implications for fibrotic lung diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1American Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Prostaglandin D2inhibits TGF-β1-induced epithelial-to-mesenchymal transition in MDCK cellsAmerican Journal of Physiology-Renal Physiology, 2006
- Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrixProceedings of the National Academy of Sciences, 2006
- TGF-β1stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent processAmerican Journal of Physiology-Cell Physiology, 2005
- Non-Smad TGF-β signalsJournal of Cell Science, 2005
- Reactive oxygen species mediate TGF-β1-induced plasminogen activator inhibitor-1 upregulation in mesangial cellsBiochemical and Biophysical Research Communications, 2003
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997